Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 149

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 8
Chunk 149
---
 exhibits
thereto and any other document we file pursuant to the Exchange Act may be inspected without charge and copied at prescribed rates at
the U. S. Securities and Exchange Commission public reference room at 100 F Street, N. E., Room 1580, Washington D. C. 20549. You may
obtain information on the operation of the Securities and Exchange Commission’s public reference room in Washington, D. C. by calling
the U. S. Securities and Exchange Commission at 1-800-SEC-0330.

The U. S. Securities and Exchange
Commission maintains a website at www. sec. gov that contains reports, proxy and information statements and other information regarding
registrants that make electronic filings with the U. S. Securities and Exchange Commission using its EDGAR (Electronic Data Gathering,
Analysis, and Retrieval) system.

The documents concerning our
company which are referred to in this document may also be inspected at our office located at Level 3, 62 Lygon Street, Carlton, VIC 3053,
Australia.

I. Subsidiary Information

See “ C Organizational Structure”.

J. Annual Report to Security Holders

If we are required to provide an annual report
to security holders in response to the requirements of Form 6-K, we will submit the annual report to security holders in electronic format
in accordance with the EDGAR Filer Manual.

Item 11.
Quantitative and Qualitative Disclosures about Market Risk